The crystal structure of the β-catenin/ICAT complex reveals the inhibitory mechanism of ICAT

Molecular Cell

Volumn 10, Issue 3, 2002, Pages 563-571

  Graham, Thomas A ^a   Clements, Wilson K ^b   Kimelman, David ^b   Xu, Wenqing ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; INHIBITOR OF BETA CATENIN MEDIATED TRANSCRIPTION PROTEIN; LYMPHOID ENHANCER FACTOR 1; PROTEIN; PROTEIN INHIBITOR; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ARMADILLO; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; EMBRYO; FEMALE; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALIA; ARMADILLO;

EID: 0036753258     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00637-8     Document Type: Article

References (58)

1. Barker N., Morin P.J., Clevers H. The yin-yang of TCF/β-catenin signaling. Adv. Cancer Res. 77:2000;1-24.
2. Barker N., Hurlstone A., Musisi H., Miles A., Bienz M., Clevers H. The chromatin remodelling factor Brg-1 interacts with β-catenin to promote target gene activation. EMBO J. 20:2001;4935-4943.
3. Bienz M., Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 103:2000;311-320.
4. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921.
5. Conacci-Sorrell M., Zhurinsky J., Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Invest. 109:2002;987-991.
6. Daniels D.L., Weis W.I. ICAT inhibits β-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. Mol. Cell. 10:2002;573-584. this issue,
7. Farr G.H. III, Ferkey D.M., Yost C., Pierce S.B., Weaver C., Kimelman D. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J. Cell Biol. 148:2000;691-702.
8. Fuerer C., Iggo R. Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway. Gene Ther. 9:2002;270-281.
9. Gottardi C.J., Gumbiner B.M. Adhesion signaling. how β-catenin interacts with its partners Curr. Biol. 11:2001;R792-R794.
10. Graham T.A., Weaver C., Mao F., Kimelman D., Xu W. Crystal structure of a β-catenin/Tcf complex. Cell. 103:2000;885-896.
11. Graham T.A., Ferkey D.M., Mao F., Kimelman D., Xu W. Tcf4 can specifically recognize β-catenin using alternative conformations. Nat. Struct. Biol. 8:2001;1048-1052.
12. Harwood A.J. Signal transduction in development. holding the key Dev. Cell. 2:2002;384-385.
13. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.
14. Hecht A., Kemler R. Curbing the nuclear activities of β-catenin. Control over Wnt target gene expression. EMBO Rep. 1:2000;24-28.
15. Hecht A., Litterst C.M., Huber O., Kemler R. Functional characterization of multiple transactivating elements in β-catenin, some of which interact with the TATA-binding protein in vitro. J. Biol. Chem. 274:1999;18017-18025.
16. Hecht A., Vleminckx K., Stemmler M.P., van Roy F., Kemler R. The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates. EMBO J. 19:2000;1839-1850.
17. Huber A.H., Weis W.I. The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell. 105:2001;391-402.
18. Katoh M. Molecular cloning and characterization of LZIC, a novel gene encoding ICAT homologous protein with leucine zipper domain. Int. J. Mol. Med. 8:2001;611-615.
19. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
20. Kramps T., Peter O., Brunner E., Nellen D., Froesch B., Chatterjee S., Murone M., Zullig S., Basler K. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin-TCF complex. Cell. 109:2002;47-60.
21. Kraulis P.J. Molscript. a program to produce both detailed and schematic plots of protein structure J. Appl. Crystallogr. 24:1991;946-950.
22. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. Procheck. a program to check the stereochemical quality of protein structures J. Appl. Crystallogr. 26:1993;283-291.
23. Levine E., Lee C.H., Kintner C., Gumbiner B.M. Selective disruption of E-cadherin function in early Xenopus embryos by a dominant negative mutant. Development. 120:1994;901-909.
24. McRee D.E. XtalView/Xfit - a versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125:1999;156-165.
25. Merritt E.A., Murphy M.E.P. RASTER3D version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr. D. 50:1994;869-873.
26. Miyagishi M., Fujii R., Hatta M., Yoshida E., Araya N., Nagafuchi A., Ishihara S., Nakajima T., Fukamizu A. Regulation of Lef-mediated transcription and p53-dependent pathway by associating β-catenin with CBP/p300. J. Biol. Chem. 275:2000;35170-35175.
27. Moon R.T., Christian J.L. Microinjection and expression of synthetic mRNAs in Xenopus embryos. Technique. 1:1989;76-89.
28. Moon R.T., Kimelman D. From cortical rotation to organizer gene expression. toward a molecular explanation of axis specification in Xenopus Bioessays. 20:1998;536-545.
29. Morin P.J. β-catenin signaling and cancer. Bioessays. 21:1999;1021-1030.
30. Nagafuchi A. Molecular architecture of adherens junctions. Curr. Opin. Cell Biol. 13:2001;600-603.
31. Navaza J. AMoRe. an automated package for molecular replacement Acta Crystallogr. A. 50:1994;157-163.
32. Newport J., Kirschner M. A major developmental transition in early Xenopus embryos. I. Characterization and timing of cellular changes at the midblastula stage Cell. 30:1982;675-686.
33. Nicholls A., Sharp K.A., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins. 11:1991;281-296.
34. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Carter C.W.J., Sweet R.M. Methods in Enzymology, Volume 276. 1997;Academic Press, New York. 307-326.pp.
35. Parker D.S., Jemison J., Cadigan K.M. Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development. 129:2002;2565-2576.
36. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 287:2000;1606-1609.
37. Pokutta S., Weis W.I. The cytoplasmic face of cell contact sites. Curr. Opin. Struct. Biol. 12:2002;255-262.
38. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851.
39. Poy F., Lepourcelet M., Shivdasani R.A., Eck M.J. Structure of a human Tcf4-β-catenin complex. Nat. Struct. Biol. 8:2001;1053-1057.
40. Provost E., Rimm D.L. Controversies at the cytoplasmic face of the cadherin-based adhesion complex. Curr. Opin. Cell Biol. 11:1999;567-572.
41. Reifenberger J., Knobbe C.B., Wolter M., Blaschke B., Schulte K.W., Pietsch T., Ruzicka T., Reifenberger G. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int. J. Cancer. 100:2002;549-556.
42. Roose J., Clevers H. TCF transcription factors. molecular switches in carcinogenesis Biochim. Biophys. Acta. 1424:1999;M23-M37.
43. Roura S., Miravet S., Piedra J., Garcia de Herreros A., Dunach M. Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J. Biol. Chem. 274:1999;36734-36740.
44. Rubinfeld B., Souza B., Albert I., Muller O., Chamberlain S.H., Masiarz F.R., Munemitsu S., Polakis P. Association of the APC gene product with β-catenin. Science. 262:1993;1731-1734.
45. Seidensticker M.J., Behrens J. Biochemical interactions in the wnt pathway. Biochim. Biophys. Acta. 1495:2000;168-182.
46. 2 arrest and cell death in tumor cell mutants for adenomatous polyposis coli, β-catenin, or Axin. Cancer Res. 62:2002;3322-3326.
47. Sharpe C., Lawrence N., Martinez Arias A. Wnt signalling. a theme with nuclear variations Bioessays. 23:2001;311-318.
48. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA. 96:1999;5522-5527.
49. Sun Y., Kolligs F.T., Hottiger M.O., Mosavin R., Fearon E.R., Nabel G.J. Regulation of β-catenin transformation by the p300 transcriptional coactivator. Proc. Natl. Acad. Sci. USA. 97:2000;12613-12618.
50. Tago K., Nakamura T., Nishita M., Hyodo J., Nagai S., Murata Y., Adachi S., Ohwada S., Morishita Y., Shibuya H., Akiyama T. Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein. Genes Dev. 14:2000;1741-1749.
51. Takemaru K.I., Moon R.T. The transcriptional coactivator CBP interacts with β-catenin to activate gene expression. J. Cell Biol. 149:2000;249-254.
52. Turner D.L., Weintraub H. Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev. 8:1994;1434-1447.
53. Tetsu O., McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
54. Thompson B., Townsley F., Rosin-Arbesfeld R., Musisi H., Bienz M. A new nuclear component of the Wnt signalling pathway. Nat. Cell Biol. 4:2002;367-373.
55. Tutter A.V., Fryer C.J., Jones K.A. Chromatin-specific regulation of LEF-1-β-catenin transcription activation and inhibition in vitro. Genes Dev. 15:2001;3342-3354.
56. van Noort M., Clevers H. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev. Biol. 244:2002;1-8.
57. Wodarz A., Nusse R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14:1998;59-88.
58. Yost C., Torres M., Miller J.R., Huang E., Kimelman D., Moon R.T. The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10:1996;1443-1454.